Vizionfocus Inc. (TPE:4771)
Taiwan · Delayed Price · Currency is TWD 175.00
-2.50 (-1.41%)
At close: Mar 13, 2026
Vizionfocus Revenue
In the year 2025, Vizionfocus had annual revenue of 3.49B TWD with 16.17% growth. Vizionfocus had revenue of 950.94M in the quarter ending December 31, 2025, with 24.84% growth.
Revenue
3.49B
Revenue Growth
+16.17%
P/S Ratio
2.94
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.49B | 485.44M | 16.17% |
| Dec 31, 2024 | 3.00B | 429.81M | 16.71% |
| Dec 31, 2023 | 2.57B | 737.88M | 40.23% |
| Dec 31, 2022 | 1.83B | 414.63M | 29.21% |
| Dec 31, 2021 | 1.42B | 564.54M | 66.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pegavision | 7.04B |
| Visco Vision | 4.22B |
| Formosa Optical Technology | 4.13B |
| St.Shine Optical | 4.12B |
| Pacific Hospital Supply | 2.41B |
| Nang Kuang Pharmaceutical | 2.16B |
| Bioteque | 2.14B |
| Bionime | 1.91B |